about
Viscoelasticity of biofilms and their recalcitrance to mechanical and chemical challenges.Antibiotic Resistance and Virulence Phenotypes of Recent Bacterial Strains Isolated from Urinary Tract Infections in Elderly Patients with Prostatic Disease.Pathogenicity islands in bacterial pathogenesisThe asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urineMolecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen.Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli.Theodore E. Woodward Award: host-pathogen interactions in community-acquired urinary tract infections.Characterization of an iroBCDEN gene cluster on a transmissible plasmid of uropathogenic Escherichia coli: evidence for horizontal transfer of a chromosomal virulence factor.F9 fimbriae of uropathogenic Escherichia coli are expressed at low temperature and recognise Galβ1-3GlcNAc-containing glycansRole of capsule and O antigen in the virulence of uropathogenic Escherichia coli.Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073.Global gene expression profiling of asymptomatic bacteriuria Escherichia coli during biofilm growth in human urineRole of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage.Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract.Whole-genome sequencing of uropathogenic Escherichia coli reveals long evolutionary history of diversity and virulence.Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?Phenotypic study of virulence factors in Escherichia coli isolated from antenatal cases, catheterized patients, and faecal flora.Adhesion of human and animal Escherichia coli strains in association with their virulence-associated genes and phylogenetic origins.Genetics of innate immunity and UTI susceptibility.Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections.Proteomic analysis of uropathogenic Escherichia coli.Characterization of (Uropathogenic) E. coli isolated from urinary tract infections: phylogenetic typing and distribution of virulence-associated traits.Bacterial control of host gene expression through RNA polymerase II.Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.Examination of the source and extended virulence genotypes of Escherichia coli contaminating retail poultry meat.Antimicrobial photodynamic therapy mediated by methylene blue and potassium iodide to treat urinary tract infection in a female rat model.[Study on virulence factors associated with biofilm formation and phylogenetic groupings in Escherichia coli strains isolated from patients with cystitis].Intranasal immunization with a recombinant truncated FimH adhesin adjuvanted with CpG oligodeoxynucleotides protects mice against uropathogenic Escherichia coli challenge.Subtyping of uropathogenic Escherichia coli according to the pathogenicity island encoding uropathogenic-specific protein: comparison with phylogenetic groups.Lectins as Promising Therapeutics for the Prevention and Treatment of HIV and Other Potential Coinfections.
P2860
Q28649640-871E63AA-0634-4E81-B3F0-C3207248BC32Q33847272-D3B6A75D-8D9D-4E63-BEBF-ACBCD6A6B962Q34290188-17543BA5-32E1-43A2-B7D4-992A37E1E1B2Q34301103-342A8282-2E38-414A-A89E-2C7A139F7CD1Q34301228-44AFB481-7FAF-4019-9E50-484BFC09909EQ34596075-6E0E8F0C-97FF-4523-BC5D-1F643AF75855Q34767242-7EE9EF88-3879-42FE-B020-A177A3ADF0AEQ35011222-B17F69FF-A281-4BE3-85E9-4CA3A2AB3BCAQ35132191-5BFFFDC1-BD5F-4791-B271-EF978A225A83Q35145454-D7BD63FE-F8C9-4256-9C83-D49EF05DA433Q35665359-F366B04B-A4BE-43DB-9501-3DA289C0B962Q35689183-60A778BF-D883-4697-8B85-E963A9B05C7DQ35852635-93D17301-E5EE-4AA7-AD8D-65BAFD780B43Q35913583-2AEA6D00-05EE-4F75-9AB1-88B4E26F4617Q35931536-53E290C4-6F74-4A8A-B7B9-C9D733507DCFQ35949736-6CEF8849-AA81-425C-B9D3-2469F60908EDQ36163174-723FA0E3-851F-48B3-8BBE-4655706E4EA9Q36258460-DCEE4B6E-9520-435A-842B-65B2CFC48371Q36554113-9A955837-B4E5-4F65-AAD2-E5FF518E07EEQ37263655-2DECAA1D-FB8C-47AC-8DD7-A11CBFBCA08FQ37900471-EE203AB7-9A55-43E9-9A15-80151ECAF2C9Q37983470-42F9122C-0B41-4A64-810B-4B1B2A361143Q38176076-FBC501C3-89C0-4A06-91D4-2F3D60FDAD30Q40134373-85317358-1FE5-4B13-B503-C9E988819AB6Q41287997-0284F91E-E15B-4D98-8BD2-571AA8F7BDF4Q41873330-B7AB8CBD-F8FA-482C-B95B-0CD84E60514CQ42139965-C8D77ABB-1273-48A5-B749-BEB414FCB04EQ54217724-2041B250-0EF0-49EE-85F1-6DEE22C9974AQ54407923-91261938-ED24-495D-AA6D-198AC4A578B9Q54448728-06063658-0915-4936-9AF8-78C4169A1229Q54459916-1D6C008E-F37E-4BEB-9029-26B3330D76ADQ55120164-AEB71076-9832-46D3-B222-7C996514506F
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Virulence factors of uropathogens.
@ast
Virulence factors of uropathogens.
@en
Virulence factors of uropathogens.
@nl
type
label
Virulence factors of uropathogens.
@ast
Virulence factors of uropathogens.
@en
Virulence factors of uropathogens.
@nl
prefLabel
Virulence factors of uropathogens.
@ast
Virulence factors of uropathogens.
@en
Virulence factors of uropathogens.
@nl
P2093
P1476
Virulence factors of uropathogens.
@en
P2093
Joerg Hacker
Tobias A Oelschlaeger
Ulrich Dobrindt
P356
10.1097/00042307-200201000-00007
P577
2002-01-01T00:00:00Z